Switch to:
PowerShares Dynamic Biotech &Genome(ETF) (:PBE)
Enterprise Value
$914.00 Mil (As of Today)

Think of enterprise value as the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents.

EV/EBIT ratio is calculated as enterprise value divided by its EBIT. As of today, PowerShares Dynamic Biotech &Genome(ETF)'s enterprise value is $914.00 Mil. PowerShares Dynamic Biotech &Genome(ETF) does not have enough years/quarters to calculate its operating income for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate PowerShares Dynamic Biotech &Genome(ETF)'s EV/EBIT ratio at this moment.

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, PowerShares Dynamic Biotech &Genome(ETF)'s enterprise value is $914.00 Mil. PowerShares Dynamic Biotech &Genome(ETF) does not have enough years/quarters to calculate its earnings before depreciation and amortization for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate PowerShares Dynamic Biotech &Genome(ETF)'s EV/EBITDA ratio at this moment.

EV/Revenue ratio is calculated as enterprise value divided by its Revenue. As of today, PowerShares Dynamic Biotech &Genome(ETF)'s enterprise value is $914.00 Mil. PowerShares Dynamic Biotech &Genome(ETF) does not have enough years/quarters to calculate its revenue for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate PowerShares Dynamic Biotech &Genome(ETF)'s EV/Revenue ratio at this moment.


Definition

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents.

PowerShares Dynamic Biotech &Genome(ETF)'s Enterprise Value for the fiscal year that ended in . 20 is calculated as

Enterprise Value (A: . 20 )
=Market Cap+Preferred Stock+Long-Term Debt
=++
+Short-Term Debt Without Lease+Minority Interest-Cash and Cash Equivalents
++-
=0.00

PowerShares Dynamic Biotech &Genome(ETF)'s Enterprise Value for the quarter that ended in . 20 is calculated as

Enterprise Value (Q: . 20 )
=Market Cap+Preferred Stock+Long-Term Debt
=++
+Short-Term Debt Without Lease+Minority Interest-Cash and Cash Equivalents
++-
=0.00

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of enterprise value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.


Related Terms

Market Cap, Preferred Stock, Long-Term Debt, Cash and Cash Equivalents


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

PowerShares Dynamic Biotech &Genome(ETF) Annual Data

ev 0.000.000.000.000.000.000.000.000.000.00

PowerShares Dynamic Biotech &Genome(ETF) Semi-Annual Data

ev 0.000.000.000.000.000.000.000.000.000.00
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK